Clinical trial condition

IPF

Explore clinical trials studying IPF. Study availability and eligibility vary by location and protocol.

31 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

IPF trial results

Not yet recruiting

A PhaseⅠ Study of HW252001 in Healthy Subjects

NCT07493031

Conditions: IPF
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Active, not recruiting

Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib

NCT06714812

Conditions: IPF
Locations: IRCCS Azienda Ospedaliera-Universitaria di Bologna Bologna, Italy

View Trial Details

Active, not recruiting

Assessment of Self-Care in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT07139925

Conditions: IPF
Locations: Fondazione Policlinico Universitario Agostino Gemelli Roma, Italy

View Trial Details

Active, not recruiting

Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)

NCT05983471

Conditions: Chronic Cough, Cough, Coughing, +13 more
Locations: Aditya Multi Specialty Hospital Guntur, Andhra Pradesh, India

KLE's Dr Prabhakar Kore Hospital & Medical Research Centre Belagavi, Karnataka, India

ACE Hospital and Research Centre Pune, Maharashtra, India

Hindusthan Hospital Coimbatore, Tamil Nadu, India

View Trial Details

Active, not recruiting

Advancing Prevention of Pulmonary Fibrosis

NCT04564183

Conditions: Fibrosis, ILD, IPF, +6 more
Locations: University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

View Trial Details

Active, not recruiting

Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

NCT05570058

Conditions: Fibrosis, IPF, Pathologic Processes, +1 more
Locations: Medical University of Vienna Vienna, Austria

E PNE UZ Leuven Leuven, Belgium

CHU De Liège Liège, Belgium

Pneumologicka klinika 1.LF UK a Prague, Czechia

View all 31 locations

View Trial Details

Completed

Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF

NCT06181370

Conditions: IPF
Locations: Medicines Evaluation Unit Ltd. an IQVIA business Manchester, United Kingdom

View Trial Details

Completed

Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis

NCT06714188

Conditions: IPF
Locations: IRCCS Azienda Ospedaliera-Universitaria di Bologna Bologna, Italy

View Trial Details

Completed

Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis

NCT02503657

Conditions: Fibrosis, IPF, Idiopathic Pulmonary Fibrosis, +6 more
Locations: Penn State University College of Medicine, Milton S. Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects

NCT05895565

Conditions: IPF
Locations: The Second Hospital of Anhui Medical University Hefei, Anhui, China

China-Japan Friendship Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

Tongji Hospital Tongji Medical College of HUST Wuhan, Hubei, China

View Trial Details

IPF

IPF trial results

Related conditions